GreenJay Therapeutics
Pre-clinicalGreenJay Therapeutics, Inc. (GreenJay) is a late-stage pharmaceutical company based in Houston, Texas, focused on reformulation of drugs to improve clinical outcomes. The Company has developed a new intravenous (IV) formulation of busulfan which we believe will reduce toxicity risks to the patient. Busulfan currently is used as a pretreatment related to stem cell transplantation. Current IV formulations of busulfan on the market contain a “Class 2” solvent, for which the FDA recommends strict...
About
GreenJay Therapeutics, Inc. (GreenJay) is a late-stage pharmaceutical company based in Houston, Texas, focused on reformulation of drugs to improve clinical outcomes. The Company has developed a new intravenous (IV) formulation of busulfan which we believe will reduce toxicity risks to the patient. Busulfan currently is used as a pretreatment related to stem cell transplantation. Current IV formulations of busulfan on the market contain a “Class 2” solvent, for which the FDA recommends strict...
Funding History
1Total raised: $5M
Company Info
Contact
Sectors
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile